Urinary excretion of Bowman-Birk inhibitor in humans after soy consumption as determined by a monoclonal antibody-based immunoassay

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 7, 2000, Pages 741-747

  Wan, X Steven ^a   Lu, Lee Jane W ^b   Anderson, Karl E ^b   Ware, Jeffrey H ^a   Kennedy, Ann R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHYMOTRYPSIN; CREATININE; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR;

ARTICLE; CHEMOPROPHYLAXIS; CREATININE BLOOD LEVEL; DISULFIDE BOND; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGICAL DATA; FOOD INTAKE; GASTROINTESTINAL TRACT EXAMINATION; HUMAN; IMMUNOASSAY; PRIORITY JOURNAL; SOYBEAN; URINARY EXCRETION;

ADULT; ANTIBODIES, MONOCLONAL; BIOLOGICAL AVAILABILITY; CREATININE; DIET; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; SOYBEANS; TRYPSIN INHIBITOR, BOWMAN-BIRK SOYBEAN; TRYPSIN INHIBITORS;

EID: 0033942129     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Birk, Y. The Bowman-Birk protease inhibitor: trypsin-and chymotrypsin-inhibitor from soybeans. Int. J. Peptide Protein Res., 25: 113-131, 1985.
2. Larionova, N. I., Gladysheva, I. P., Tikhonova, T. V., and Kazanskaia, N. F. Inhibition of cathepsin G and elastase from human granulocytes by multiple forms of the Bowman-Birk type of soy inhibitor. Biochemistry (Moscow), 58: 1437-1444, 1993.
3. Larionova, N. I., Gladysheva, I. P., Tikhonova, T. V., and Kazanskaya, N. F. Inhibition of cathepsin G and human granulocyte elastase by multiple forms of Bowman-Birk type soybean inhibitor (in Russian), Biokhimiya, pp. 1046-1052. New York: Plenum Publishing Corp., 1994.
4. Ware, J. H., Wan, X. S., Rubin, H., Schechter, N. M., and Kennedy, A. R. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase. Arch. Biochem. Biophys., 344: 133-138, 1997.
5. Kennedy, A. R. In vitro studies of anticarcinogenic protease inhibitors. In: W. Troll and A. R. Kennedy (eds.), Protease Inhibitors as Cancer Chemopreventive Agents, pp. 65-91. New York: Plenum Publishing Corp., 1993.
6. Kennedy, A. R. Anticarcinogenic activity of protease inhibitors: overview. In: W. Troll and A. R. Kennedy (eds.), Protease Inhibitors as Cancer Chemopreventive Agents, pp. 9-64. New York: Plenum Publishing Corp., 1993.
7. Kennedy, A. R. Chemopreventive agents: protease inhibitors. Pharmacol. Ther., 78: 167-209, 1998.
8. Fontham, E., and Correa, P. The epidemiologic approach to the study of protease inhibitors. In: W. Troll and A. R. Kennedy (eds.), Protease Inhibitors as Cancer Chemopreventive Agents, pp. 1-8. New York: Plenum Publishing Corp., 1993.
9. Meyskens, F. L., Jr., Armstrong, W. B., Wan, X. S., Taylor, T. H., Jenson, J., Thompson, W., Nguyen, Q. A., and Kennedy, A. R. Bowman-Birk inhibitor concentrate (BBIC) affects oral leukoplakia lesion size, neu protein levels and proteolytic activity in buccal mucosal cells. Proc. Am. Assoc. Cancer Res., 40: 432, 1999.
10. Brandon, D. L., Bates, A. H., and Friedman, M. Monoclonal antibody-based enzyme immunoassay of the Bowman-Birk protease inhibitor of soybeans. J. Agric. Food Chem., 37: 1192-1196, 1989.
11. Brandon, D. L. Antigenicity of soybean protease inhibitors. In: W. Troll and A. R. Kennedy (eds.), Protease Inhibitors as Cancer Chemopreventive Agents, pp. 107-129. New York: Plenum Publishing Corp., 1993.
12. Flecker, P. Chemical synthesis, molecular cloning and expression of gene coding for a Bowman-Birk-type proteinase inhibitor. Eur. J. Biochem., 166: 151-156, 1987.
13. Wan, X. S., Koch, C. J., Lord, E. M., Manzone, H., Billings, P. C., Donahue, J. J., Odell, C. S., Miller, J. H., Schmidt, N. A., and Kennedy, A. R. Monoclonal antibodies differentially reactive with native and reductively modified Bowman-Birk protease inhibitor. J. Immunol. Methods, 180: 117-130, 1995.
14. Kock, C. J., and Raleigh, J. A. Radiolytic reduction of protein and nonprotein disulfides in the presence of formate: a chain reaction. Arch. Biochem. Biophys., 287: 75-84, 1991.
15. Lord, E. M., Harwell, L., and Koch, C. J. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. Cancer Res., 53: 5721-5726, 1993.
16. Haeckel, R. Assay of creatinine in serum, with use of fuller's earth to remove interferents. Clin. Chem., 27: 179-183, 1981.
17. Meyer, M., Smith, S., and Meyer, R. A., Jr. Creatinine assay by the fuller's earth procedure or by enzymatic determination is adequate for urine but not plasma of mice. Comp. Biochem. Physiol., 106B: 685-689, 1993.
18. Armstrong, W. B., Kennedy, A. R., Wan, X. S., Atiba, J., McLaren, C. E., and Meyskens, F. L., Jr. Single dose administration of Bowman-Birk inhibitor concentrate (BBIC) in patients with oral leukoplakia. Cancer Epidemiol. Biomarkers Prev., 9: 43-47, 2000.
19. Brandon, D. L., Bates, A. H., and Friedman. M. ELISA analysis of soybean trypsin inhibitors in processed foods. In: M. Friedman (ed.), Nutritional and Toxicological Consequences of Food Processing, pp. 321-337. New York: Plenum Publishing Corp., 1991.
20. DiPietro, C. M., and Liener, I. E. Soybean protease inhibitors in foods. J. Food Sci., 54: 606-609, 617, 1989.
21. Yavelow, J., Collins, M., Birk, Y., Troll, W., and Kennedy, A. R. Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress X-ray induced transformation in vitro. Proc. Natl. Acad. Sci. USA, 82: 5395-5399, 1985.
22. Yavelow, J., Finlay, T. H., Kennedy, A. R., and Troll, W. Bowman-Birk soybean protease inhibitor as an anticarcinogen. Cancer Res., 43: 2454-2459, 1983.
23. Billings, P. C., St. Clair, W. H., Maki, P. A., and Kennedy, A. R. Distribution of the Bowman Birk protease inhibitor in mice following oral administration. Cancer Lett., 62: 191-197, 1992.
24. Madar, Z., Gertler, A., and Birk, Y. The fate of the Bowman-Birk trypsin inhibitor from soybeans in the digestive tract of chicks. Comp. Biochem. Physiol., 62A: 1057-1061, 1979.